Fresenius Medical Care AG (FMS)
NYSE: FMS · Real-Time Price · USD
22.74
-0.21 (-0.92%)
At close: Nov 10, 2026, 4:00 PM EST
22.74
0.00 (0.00%)
After-hours: Nov 10, 2026, 4:10 PM EST

Fresenius Medical Care AG Cash Flow Statement

Millions EUR. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
822.76978.37537.91499673.41969.31
Depreciation & Amortization
1,3641,4001,4831,6131,7201,585
Other Amortization
63.2463.2452.7---
Loss (Gain) From Sale of Assets
15.41123.24-12.17-12.9-99.2744.09
Asset Writedown & Restructuring Costs
205.1837206.72139.24118.2338.31
Loss (Gain) on Equity Investments
-59.92-181.37-134.88-121.79-66.56-92.18
Other Operating Activities
58.39122.12-191.3-48.76-50.542.37
Change in Accounts Receivable
18.31-69.06-73.48-151.84-46.68-163.2
Change in Inventory
-308.25-248.66107.9-13.14-204.31-48.53
Change in Accounts Payable
233.5612.45155.59108.48-356.79-363.96
Change in Income Taxes
366.78236.61482.27472.08325.68313.71
Change in Other Net Operating Assets
106.77206.9-227.97145.7154.03164.2
Operating Cash Flow
2,8862,6812,3862,6292,1672,489
Operating Cash Flow Growth
14.95%12.36%-9.23%21.29%-12.94%-41.19%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,091-915.37-699.36-684.6-723.99-854.36
Sale of Property, Plant & Equipment
17.5116.714.116.1436.2124.42
Cash Acquisitions
-14.75-15.3-0.18-3.1410.53-324.81
Divestitures
61.39202.14629.75172.260.1652.44
Sale (Purchase) of Intangibles
-4.67-4.67-8.54-26.37-46.35-32.36
Investment in Securities
-36.38-6.03-20.71-18.46-71.28-61.58
Investing Cash Flow
-1,068-722.53-84.94-544.23-734.73-1,196

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-156.4684.8165.34717.091,804
Long-Term Debt Issued
-1,62361.51417.881,0821,244
Total Debt Issued
1,2251,779146.33483.211,7993,048
Short-Term Debt Repaid
--140.81-540.5-244.98-1,302-627.25
Long-Term Debt Repaid
--1,489-1,534-1,497-1,520-2,780
Lease Payments
-624.69-649.04-676.51-727.37-775.15-696.95
Total Debt Repaid
-1,304-1,629-2,075-1,742-2,822-3,407
Net Debt Issued (Repaid)
-79.29149.58-1,928-1,259-1,023-358.9
Issuance of Common Stock
----20.156.51
Repurchase of Common Stock
-1,210-585.29----
Common Dividends Paid
-400.16-422.52-349.16-328.62-395.56-392.46
Other Financing Activities
-288.8-544.99-291.89-270.75-218.91-279.54
Financing Cash Flow
-1,979-1,403-2,569-1,859-1,617-1,024

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
3.75-141.4826.2-72.61-23.16131.23
Net Cash Flow
-156.73413.79-241.9153.44-207.87400.12

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
1,7951,7661,6871,9441,4431,635
Free Cash Flow Growth
0.96%4.67%-13.24%34.70%-11.73%-48.60%
Free Cash Flow Margin
9.21%9.00%8.72%9.99%7.44%9.28%
Free Cash Flow Per Share
6.576.065.756.634.925.58
Levered Free Cash Flow
1,4931,5562,0311,3121,0231,697
Unlevered Free Cash Flow
1,7351,7972,2861,5781,2481,918
Free Cash Flow After Leases
1,1701,1171,0101,217668.24938.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
354.68359.98381.23394.54350.68341.63
Cash Income Tax Paid
247.4225.75444.59410.13334.62345.05
Change in Working Capital
417.17138.24444.31561.28-128.07-97.77
SEC Filings: 10-K · 10-Q